SUSQUEHANNA INTERNATIONAL GROUP, LLP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$15,540
-42.4%
15,922
-32.8%
0.00%
Q3 2022$27,000
-79.5%
23,700
-66.7%
0.00%
Q2 2022$132,000
-89.8%
71,116
-83.4%
0.00%
Q1 2022$1,295,000
-60.4%
427,334
-50.6%
0.00%
Q4 2021$3,272,000
-12.7%
865,588
+19.4%
0.00%
Q3 2021$3,748,000
+110.2%
724,901
+55.7%
0.00%
Q2 2021$1,783,000
+675.2%
465,520
+405.5%
0.00%
Q4 2020$230,000
+70.4%
92,084
+40.8%
0.00%
Q3 2020$135,000
+321.9%
65,390
+540.6%
0.00%
Q2 2020$32,000
-42.9%
10,208
-58.7%
0.00%
Q1 2020$56,000
-24.3%
24,704
+20.1%
0.00%
Q4 2019$74,000
-90.7%
20,563
-91.2%
0.00%
Q3 2019$796,000
+30.3%
233,417
+79.4%
0.00%
Q2 2019$611,000
+157.8%
130,092
+46.4%
0.00%
Q4 2018$237,000
-69.6%
88,846
-36.2%
0.00%
Q3 2018$779,000
-20.2%
139,259
-27.7%
0.00%
Q2 2018$976,000
-49.1%
192,503
-31.6%
0.00%
Q1 2018$1,919,000
+362.4%
281,232
+411.3%
0.00%
Q4 2017$415,000
+336.8%
55,003
+233.4%
0.00%
Q3 2017$95,000
-73.3%
16,500
-87.2%
0.00%
Q2 2015$356,000129,3900.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders